Clinical Trial

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets

Name: Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets — clinical trial record (NCT07710326)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo-controlled, multiple ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV261 tablets in healthy adults.

Trial Details

NCT Number	NCT07710326
Lead Sponsor	Vigonvita Life Sciences
Conditions	Healthy Volunteers
Enrollment	16 participants
Start Date	2026-08-01
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-17